Journal article

Novel F-18-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease

Nobuyuki Okamura, Shozo Furumoto, Ryuichi Harada, Tetsuro Tago, Takeo Yoshikawa, Michelle Fodero-Tavoletti, Rachel S Mulligan, Victor L Villemagne, Hiroyasu Akatsu, Takayuki Yamamoto, Hiroyuki Arai, Ren Iwata, Kazuhiko Yanai, Yukitsuka Kudo

Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2013

University of Melbourne Researchers

Grants

Awarded by Industrial Technology Research Grant Program of the NEDO in Japan


Awarded by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan


Funding Acknowledgements

The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was supported by the research fund from GE Healthcare; the Industrial Technology Research Grant Program of the NEDO in Japan (09E51025a); Health and Labor Sciences Research grants from the Ministry of Health, Labor, and Welfare of Japan; and a Grant-in-Aid for Scientific Research (B) (23390297) and "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No other potential conflict of interest relevant to this article was reported.